NKGen Biotech, Inc. (NKGN)
0.011
0.00 (0.00%)
USD |
OTCM |
Nov 06, 16:00
NKGen Biotech Total Liabilities (Quarterly)
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2025 | 66.17M |
| December 31, 2024 | 86.14M |
| September 30, 2024 | 62.04M |
| June 30, 2024 | 85.36M |
| March 31, 2024 | 71.37M |
| December 31, 2023 | 75.17M |
| September 30, 2023 | 65.84M |
| June 30, 2023 | 9.348M |
| March 31, 2023 | 6.291M |
| Date | Value |
|---|---|
| December 31, 2022 | 14.77M |
| September 30, 2022 | 5.584M |
| June 30, 2022 | 6.234M |
| March 31, 2022 | 11.08M |
| December 31, 2021 | 13.47M |
| September 30, 2021 | 12.42M |
| June 30, 2021 | 17.37M |
| March 31, 2021 | 0.2902M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 289.47M |
| C4 Therapeutics, Inc. | 103.63M |
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |